---
title: "减肥药物开发商 Kailera 在纳斯达克首次亮相中股价飙升 62.5%"
type: "News"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/283179748.md"
description: "4 月 17 日（路透社）- Kailera Therapeutics 在周五的纳斯达克首秀中股价上涨了 62.5%，该减肥药开发公司在美国首次公开募股中筹集了 6.25 亿美元。（班加罗尔的 Manya Saini 报道；Sahal Muhammed 编辑）"
datetime: "2026-04-17T17:27:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/283179748.md)
  - [en](https://longbridge.com/en/news/283179748.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/283179748.md)
---

# 减肥药物开发商 Kailera 在纳斯达克首次亮相中股价飙升 62.5%

April 17 (Reuters) - Kailera Therapeutics' shares rose 62.5% in their Nasdaq debut on Friday after the weight-loss drug developer raised $625 million in its U.S. initial public offering. (Reporting by Manya Saini in Bengaluru; Editing by Sahal Muhammed)

### 相关股票

- [GRTX.US](https://longbridge.com/zh-CN/quote/GRTX.US.md)
- [BBH.US](https://longbridge.com/zh-CN/quote/BBH.US.md)
- [IBB.US](https://longbridge.com/zh-CN/quote/IBB.US.md)
- [SBIO.US](https://longbridge.com/zh-CN/quote/SBIO.US.md)
- [LABU.US](https://longbridge.com/zh-CN/quote/LABU.US.md)
- [XBI.US](https://longbridge.com/zh-CN/quote/XBI.US.md)
- [FBT.US](https://longbridge.com/zh-CN/quote/FBT.US.md)
- [BIB.US](https://longbridge.com/zh-CN/quote/BIB.US.md)
- [ARKG.US](https://longbridge.com/zh-CN/quote/ARKG.US.md)
- [PBE.US](https://longbridge.com/zh-CN/quote/PBE.US.md)
- [NDAQ.US](https://longbridge.com/zh-CN/quote/NDAQ.US.md)

## 相关资讯与研究

- [CAR-T 迎接新时代](https://longbridge.com/zh-CN/news/286999381.md)
- [创胜集团医药-B 合作伙伴 INHIBRX 报告 OZEKIBART 的 CRC 最新积极数据并宣布就治疗软骨肉瘤提交美国 BLA 申请](https://longbridge.com/zh-CN/news/287126678.md)
- [默沙东 ADC 药物达 III 期主要终点](https://longbridge.com/zh-CN/news/286929703.md)
- [Tevogen Bio Q1 运营亏损收窄 48%，推进 AI 平台与细胞疗法管线](https://longbridge.com/zh-CN/news/287086570.md)
- [Scholar Rock 将出席杰富瑞全球医疗保健大会，聚焦 SMA 新药 apitegromab 关键审批](https://longbridge.com/zh-CN/news/287069556.md)